FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

409408008: Substance with angiogenesis inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2471194014 Angiogenesis inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3520688016 Substance with angiogenesis inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3520860013 Substance with angiogenesis inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

15 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with angiogenesis inhibitor mechanism of action Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Substance with angiogenesis inhibitor mechanism of action Is a Ophthalmic agent false Inferred relationship Existential restriction modifier
Substance with angiogenesis inhibitor mechanism of action Has disposition Angiogenesis inhibitor true Inferred relationship Existential restriction modifier
Substance with angiogenesis inhibitor mechanism of action Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier
Substance with angiogenesis inhibitor mechanism of action Is a Substance with effector mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bevacizumab Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing angiogenesis inhibitor Has active ingredient True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Pegaptanib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Vandetanib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Lenalidomide Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sorafenib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ranibizumab Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Axitinib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Regorafenib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Pomalidomide Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aflibercept Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial Has active ingredient False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing ranibizumab Has active ingredient False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sorafenib tosylate Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Pegaptanib sodium Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sunitinib Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sunitinib malate Is a True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aflibercept Is a False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Regorafenib Is a False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aflibercept 4mg/100microlitres solution for injection vials Has active ingredient False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aflibercept 100mg/4ml solution for infusion vials Has active ingredient False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Aflibercept 200mg/8ml solution for infusion vials Has active ingredient False Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Eylea 4mg/100microlitres solution for injection vials (Bayer Plc) Has active ingredient True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Zaltrap 100mg/4ml concentrate for solution for infusion vials (Sanofi) Has active ingredient True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier
Zaltrap 200mg/8ml concentrate for solution for infusion vials (Sanofi) Has active ingredient True Substance with angiogenesis inhibitor mechanism of action Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start